Transforming Growth Factor Beta Two in Benign and Malignant Prostate Disease

References

• Bostwick D.G. 1997 Staging prostate cancer 1997 current methods and limitations Eur. Urol. 32 Suppl. 3 2 14
   Google Scholar
• Office for National Statistics. Mortality statistics: cause. England and Wales 1993 (revised) and 1994. Series DH2 no. 21 London HMSO, 1996.
   Google Scholar
• Martin E. Lujan M. Sanchez E. Herrero A. Paez A. Berunger A. 1999 Final results of a screening campaign for prostate cancer Eur. Urol. 35 26 31
   Google Scholar
• Stamey T.A. Yang N. Hay A. McNeal J.E. Frehia F.S. Redwine E. 1987 Prostate specific antigen as a serum marker for adenocarcinoma of the prostate N. Engl. J. Med. 317 909 916
   Google Scholar
• Steiner M.S. Zhao-Zong Z. Tonb D.C. Barrack E.R. 1994 Expression of transforming growth factor-beta 1 in prostate cancer Endocrinology 135 2240 2247
   Google Scholar
• Kopp A. Jonat W. Schmahl M. Knabbe C. 1995 Transforming growth factor beta 2 levels in plasma of patients with metastatic breast cancer treated with tamoxifen Cancer Res. 55 4512 4515
   Google Scholar
• Knabbe C. Klein H. Zugmaier G. Voigt K.D. 1993 Hormonal regulation of transforming growth factor B2 expression in human prostate cancer J. Steroid Biochem. Mol. Biol. 4 137 142
   Google Scholar
• Madisen L. Webb N.R. Rose T.M. Marquardt H. Ikeda T. Twardzik D. Seyedin S. Purchio A.F. 1988 Transforming growth factor B2: cDNA cloning and sequence analysis DNA 7 1 8
   Google Scholar
• Eder E. Stenzl A. Hobisch A. Cronauer M.V. Bartsch G. Klocker H. 1996 Transforming growth factors B1 and B2 in serum and urine from patients with bladder carcinoma J. Urol. 156 953 957
   Google Scholar
• Dirix L.Y. Vermullen P.B. Pawinski A. Prove A. Benoy I. De Pooter C. Martin M. Van Oosterom 1997 Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients Br. J. Cancer 76 2 238 243
   Google Scholar
• Chan J.M. Stampfer M.J. Giovannucci E. Gann P.H. Ma J. Wilkinson P. Hennekens C.H. Pollak M. 1998 Plasma Insulin like growth factor 1 and prostate cancer risk: a prospective study Science 279 563 566
   Google Scholar
• Ivanovic V. Melman A. Davis Joseph B. Valcic M. Geliebter J. 1995 Elevated plasma levels of TGFB1 in patients with invasive prostate cancer Nat. Med. 1 282 284
   Google Scholar
• Perry K.T. Anthony C.T. Case T. Steiner S. 1997 Transforming growth factor beta as a clinical biomarker for prostate cancer Urology 49 151 155
   Google Scholar
• Kahkei Y. Oka H. Mitsumori K. Itoh N. Ogawa O. Yoshida 1996 Elevation of serum transforming growth factor B1 level in patients with metastatic prostate cancer Urol. Oncol. 2 131
   Google Scholar
• Steiner M. 1995 Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy J. Urol. 153 1085 1096
   Google Scholar
• Catalona W.J. Miller D.R. Kavoussi L.R. 1988 Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy J. Urol. 140 540 543
   Google Scholar
• Fidler I.J. Ellis M.L. 1994 The implications of angiogenesis for the biology and therapy of cancer metastasis Cell 79 185 188
   Google Scholar
• Quantikine, Human TGFB2 immunoassay catalog no DB 250 p. 17.
   Google Scholar